The Benefits of Tablet Tooling Standardization - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

The Benefits of Tablet Tooling Standardization
A single, global tooling standard would offer many benefits, but one has been slow to emerge.


Pharmaceutical Technology
Volume 35, Issue 3, pp. 152-153

Clearances and tolerances

Unlike typical mechanical processes, powder compaction inevitably results in granule coming between the lower punch tip and die bore, resulting in resistance. Consideration should be given to the clearance between such surfaces.


Figure 3: Clearances and tolerances.
Lower punch tip to die bore clearance. Clearances and tolerances (see Figure 3) are critical to ensure accurate functionality of the tooling, and reduce wear of tooling and press components. The clearances between the punch tips and die bores are important to ensure good, problemfree tablets and to eliminate problems such as capping (see Figure 4). The ISO standard stipulates the use of DIN Norm for tolerances, adopting the same size and clearance for both upper and lower punches irrespective of tablet size. This also creates a wider variation in clearance between the lower punch tip and die bore regardless of granule size, which can cause granule leakage past the lower tip, resulting in potential wear and damage to tooling and press parts.


Figure 4: A typical example of capping.
Upper punch tip to die bore clearance. ISO adoption of DIN Norm on upper punches also results in insufficient clearance leading to rejected tablets through capping. To counter this, all dies have to be tapered at both ends to enable air to escape from the tablet. This requirement increases tooling costs for the tablet manufacturer.

The Eurostandard and the TSM standard avoid these issues by adopting customized clearances, which offer advantages over ISO standards, although there are differences between the two. The Eurostandard adopts a tighter clearance range to help improve general operation and product yield.

Conclusion

Although there are other small variations between the standards, such as seal groove configuration, these variations do not prevent interchangeability and are not detrimental to the running of the tablet press. All of these differences are surmountable.

In recognition of the need to eliminate these variables and specifically take into account the sensible and efficient provisions for cross-platform/press compatibility laid out in ISO 18084, the Eurostandard has been updated to make it compatible with the ISO standard.

A single global tooling standard should be highly desirable for the industry; however, even if tablet press manufacturers could be convinced that it is in their commercial interest to adopt it, it will take time for these changes to evolve. Leading tablet-press manufacturers are always seeking to innovate and move the industry forward so tooling standards will always require revision.

In turn, this means that highquality tooling suppliers will always need to retain the ability to solve complex problems and preserve the skill set within their workforce to manufacture tooling that is compatible with any press worldwide.

In conclusion, I believe that calls for the standards laid out in ISO 18084:2005(E) to be adopted globally should be fully endorsed. However, I also believe that the Eurostandard already represents a comprehensive global standard because it is the most widely adopted tabletting tooling standard today and is compatible with ISO.

Steve Deakin is business development director at I Holland,
.


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
29%
Breakthrough designations
10%
Protecting the supply chain
43%
Expedited reviews of drug submissions
10%
More stakeholder involvement
10%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
Sandoz Wins Biosimilar Filing Race
NIH Translational Research Partnership Yields Promising Therapy
Clusters set to benefit from improved funding climate but IP rights are even more critical
Supplier Audit Program Marks Progress
FDA, Drug Companies Struggle with Compassionate Use Requests
Source: Pharmaceutical Technology,
Click here